Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
serclutamab talirine (ABBV-321)
i
Other names:
ABBV-321, ABBV 321
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(6)
News
Trials
Company:
AbbVie
Drug class:
DNA replication inhibitor, EGFR-targeted antibody-drug conjugate
Related drugs:
‹
inotuzumab ozogamicin (28)
gemtuzumab ozogamicin (24)
idarubicin (22)
bendamustine (12)
loncastuximab tesirine-lpyl (7)
trastuzumab duocarmazine (6)
MEDI7247 (6)
rovalpituzumab tesirine (5)
SGN-CD19B (5)
SOT102 (5)
MGC018 (5)
IMGN632 (4)
IMGN779 (3)
ADCT-301 (3)
BYON3521 (2)
CS5001 (2)
IKS03 (2)
ITC-6102RO (2)
NBE-002 (2)
SGN-CD123A (2)
SGN-CD352A (2)
TR1801-ADC (2)
ADCT-601 (2)
SGN-CD33A (2)
ADCT-211 (1)
ADCT-212 (1)
ADCT-701 (1)
DHES0815A (1)
MEDI3726 (1)
SGN-CD70A (1)
SC-003 (1)
ADCT-502 (0)
MDX-1203 (0)
MEDI2228 (0)
nimorazole (0)
PF-06647263 (0)
SC-006 (0)
SC-007 (0)
SYD1875 (0)
ADCT-602 (0)
HTI-1511 (7)
DM001 (6)
MRG003 (6)
LR004-VC-MMAE (5)
SHR-A1307 (4)
M1231 (3)
ABT-414 (3)
BB-1705 (2)
DM005 (2)
ABBV-221 (2)
AZD9592 (2)
BL-B01D1 (1)
ABBV-637 (0)
AVID100 (0)
CPO301 (0)
IMGN289 (0)
inotuzumab ozogamicin (28)
gemtuzumab ozogamicin (24)
idarubicin (22)
bendamustine (12)
loncastuximab tesirine-lpyl (7)
trastuzumab duocarmazine (6)
MEDI7247 (6)
rovalpituzumab tesirine (5)
SGN-CD19B (5)
SOT102 (5)
MGC018 (5)
IMGN632 (4)
IMGN779 (3)
ADCT-301 (3)
BYON3521 (2)
CS5001 (2)
IKS03 (2)
ITC-6102RO (2)
NBE-002 (2)
SGN-CD123A (2)
SGN-CD352A (2)
TR1801-ADC (2)
ADCT-601 (2)
SGN-CD33A (2)
ADCT-211 (1)
ADCT-212 (1)
ADCT-701 (1)
DHES0815A (1)
MEDI3726 (1)
SGN-CD70A (1)
SC-003 (1)
ADCT-502 (0)
MDX-1203 (0)
MEDI2228 (0)
nimorazole (0)
PF-06647263 (0)
SC-006 (0)
SC-007 (0)
SYD1875 (0)
ADCT-602 (0)
HTI-1511 (7)
DM001 (6)
MRG003 (6)
LR004-VC-MMAE (5)
SHR-A1307 (4)
M1231 (3)
ABT-414 (3)
BB-1705 (2)
DM005 (2)
ABBV-221 (2)
AZD9592 (2)
BL-B01D1 (1)
ABBV-637 (0)
AVID100 (0)
CPO301 (0)
IMGN289 (0)
›
Associations
(6)
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR overexpression
Glioblastoma
EGFR overexpression
Glioblastoma
ABBV-321
Sensitive: C2 – Inclusion Criteria
ABBV-321
Sensitive
:
C2
ABBV-321
Sensitive: C2 – Inclusion Criteria
ABBV-321
Sensitive
:
C2
EGFR overexpression
Triple Negative Breast Cancer
EGFR overexpression
Triple Negative Breast Cancer
ABT 263 + ABBV-321
Sensitive: D – Preclinical
ABT 263 + ABBV-321
Sensitive
:
D
ABT 263 + ABBV-321
Sensitive: D – Preclinical
ABT 263 + ABBV-321
Sensitive
:
D
EGFR expression
Head and Neck Cancer
EGFR expression
Head and Neck Cancer
ABBV-321
Sensitive: D – Preclinical
ABBV-321
Sensitive
:
D
ABBV-321
Sensitive: D – Preclinical
ABBV-321
Sensitive
:
D
EGFR expression
Lung Cancer
EGFR expression
Lung Cancer
ABBV-321
Sensitive: D – Preclinical
ABBV-321
Sensitive
:
D
ABBV-321
Sensitive: D – Preclinical
ABBV-321
Sensitive
:
D
EGFR overexpression
Mesothelioma
EGFR overexpression
Mesothelioma
ABBV-321
Sensitive: D – Preclinical
ABBV-321
Sensitive
:
D
ABBV-321
Sensitive: D – Preclinical
ABBV-321
Sensitive
:
D
EGFR underexpression
Colorectal Cancer
EGFR underexpression
Colorectal Cancer
ABBV-321
Sensitive: D – Preclinical
ABBV-321
Sensitive
:
D
ABBV-321
Sensitive: D – Preclinical
ABBV-321
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login